Harbor Group, Inc. Bristol Myers Squibb CO Transaction History

Harbor Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$61.91 - $67.42 $225,723 - $245,813	-3,646 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $20,531 - $23,092	-346 Reduced 8.67%	3,646 $242,000
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $230,498 - $261,196	3,992 New	3,992 $258,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Harbor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Group, Inc. with notifications on news.